If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Giovanni Grignani is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 34 Similar Profiles
Sarcoma Medicine & Life Sciences
trabectedin Medicine & Life Sciences
gemcitabine Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Osteosarcoma Medicine & Life Sciences
Cytokine-Induced Killer Cells Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Gastrointestinal Stromal Tumors Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1986 2019

Gain of FGF4 is a frequent event in KIT/PDGFRA/SDH/RAS-P WT GIST

Urbini, M., Indio, V., Tarantino, G., Ravegnini, G., Angelini, S., Nannini, M., Saponara, M., Santini, D., Ceccarelli, C., Fiorentino, M., Vincenzi, B., Fumagalli, E., Casali, P. G., Grignani, G., Pession, A., Ardizzoni, A., Astolfi, A. & Pantaleo, M. A., Sep 2019, In : Genes Chromosomes and Cancer. 58, 9, p. 636-642 7 p.

Research output: Contribution to journalArticle

Open Access
Gastrointestinal Stromal Tumors
Fibroblast Growth Factor Receptors
Intercellular Signaling Peptides and Proteins
Phosphorylation
Messenger RNA

Gain of FGF4 is a frequent event in KIT/PDGFRA/SDH/RAS-P WT GIST.

Urbini, M., Indio, V., Tarantino, G., Ravegnini, G., Angelini, S., Nannini, M., Saponara, M., Santini, D., Ceccarelli, C., Fiorentino, M., Vincenzi, B., Fumagalli, E., Casali, P. G., Grignani, G., Pession, A., Ardizzoni, A., Astolfi, A. & Pantaleo, M. A., Sep 1 2019, In : Genes Chromosomes and Cancer. 58, p. 636-642 7 p.

Research output: Contribution to journalArticle

Pazopanib for treatment of advanced extraskeletal myxoid chondrosarcoma: a multicentre, single-arm, phase 2 trial

Stacchiotti, S., Ferrari, S., Redondo, A., Hindi-Muniz, N., Palmerini, E., Vaz Salgado, M. A., Frezza, A. M., Casali, P. G., Gutierrez, A., Lopez-Pousa, A., Grignani, G., Italiano, A., LeCesne, A., Dumont, S., Blay, J. Y., Penel, N., Bernabeu, D., de Alava, E., Karanian, M., Morosi, C. & 10 others, Brich, S., Dagrada, G. P., Vallacchi, V., Castelli, C., Brenca, M., Racanelli, D., Maestro, R., Collini, P., Cruz, J. & Martin-Broto, J., Jul 19 2019, In : The Lancet. Oncology. 20, 9, p. 1252-1262 11 p.

Research output: Contribution to journalArticle

Sarcoma
Therapeutics
Solitary Fibrous Tumors
pazopanib
Extraskeletal Myxoid Chondrosarcoma

Pazopanib for treatment of advanced extraskeletal myxoid chondrosarcoma: a multicentre, single-arm, phase 2 trial

Stacchiotti, S., Ferrari, S., Redondo, A., Hindi, N., Palmerini, E., Vaz Salgado, M. A., Frezza, A. M., Casali, P. G., Gutierrez, A., Lopez-Pousa, A., Grignani, G., Italiano, A., LeCesne, A., Dumont, S., Blay, J. Y., Penel, N., Bernabeu, D., de Alava, E., Karanian, M., Morosi, C. & 10 others, Brich, S., Dagrada, G. P., Vallacchi, V., Castelli, C., Brenca, M., Racanelli, D., Maestro, R., Collini, P., Cruz, J. & Martin-Broto, J., Sep 2019, In : The Lancet. Oncology. 20, 9, p. 1252-1262 11 p.

Research output: Contribution to journalArticle

Sarcoma
Therapeutics
Solitary Fibrous Tumors
Extraskeletal Myxoid Chondrosarcoma
pazopanib

Pazopanib for treatment of advanced extraskeletal myxoid chondrosarcoma: a multicentre, single-arm, phase 2 trial.

Stacchiotti, S., Ferrari, S., Redondo, A., Hindi, N., Palmerini, E., Vaz Salgado, M. A., Frezza, A. M., Casali, P. G., Gutierrez, A., Lopez-Pousa, A., Grignani, G., Italiano, A., LeCesne, A., Dumont, S., Blay, J. Y., Penel, N., Bernabeu, D., de Alava, E., Karanian, M., Morosi, C. & 10 others, Brich, S., Dagrada, G. P., Vallacchi, V., Castelli, C., Brenca, M., Racanelli, D., Maestro, R., Collini, P., Cruz, J. & Martin-Broto, J., Sep 1 2019, In : The Lancet. Oncology. 20, p. 1252-1262 11 p.

Research output: Contribution to journalArticle